Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.1900
-0.0050 (-2.56%)
Nov 3, 2026, 11:11 AM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 58.99 million as of November 3, 2026. It is the 31,040th most valuable company in the world and the 866th biggest in Canada. Its market cap has increased by 20.78% in one year.
Market Cap
58.99M
Enterprise Value
53.88M
Revenue
802.46K
Global Rank
Country Rank
#866 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 58.99M, an increase of 608.38%. That is a compound annual growth rate of 6.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 55.89M | 27.86% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 335.37M |
| Vector Science and Therapeutics | 308.04M |
| Cannabix Technologies | 51.12M |
| Perimeter Medical Imaging AI | 27.62M |
| Cheelcare | 27.05M |
| Ventripoint Diagnostics | 15.43M |
| Conavi Medical | 15.18M |
| Frequency Exchange | 15.03M |